Local Therapy Options for Oligometastatic Disease in the Liver

Michael R. Folkert; Jeffrey Meyer

doi:10.1007/s11888-015-0279-0

Local Therapy Options for Oligometastatic Disease in the Liver

Michael R. Folkert, Jeffrey Meyer

Research output: Contribution to journal › Review article › peer-review

1 Scopus citations

Abstract

Our understanding of metastatic disease is constantly evolving. Survival outcomes for patients with colorectal cancer metastatic to the liver are poor, although a subset of patients with limited or “oligometastatic” disease may exist in a therapeutic window amenable to aggressive local intervention. The purpose of this review is to describe and compare the range of non-surgical local treatment options available for the treatment of oligometastatic colorectal disease involving the liver.

Original language	English (US)
Pages (from-to)	241-249
Number of pages	9
Journal	Current Colorectal Cancer Reports
Volume	11
Issue number	5
DOIs	https://doi.org/10.1007/s11888-015-0279-0
State	Published - Oct 28 2015
Externally published	Yes

Keywords

Chemoembolization
Intra-arterial chemotherapy
Limited metastatic disease
Liver brachytherapy
Liver metastases
Liver-directed therapy
Metastatic colorectal cancer
Oligometastases
Radioembolization
Radiofrequency ablation
SBRT
SIRT
Selective internal radiation therapy
Stereotactic body radiation therapy

ASJC Scopus subject areas

Hepatology
Oncology
Gastroenterology

Access to Document

10.1007/s11888-015-0279-0

Cite this

@article{e89a880a1b5648a6901e0466858352d4,

title = "Local Therapy Options for Oligometastatic Disease in the Liver",

abstract = "Our understanding of metastatic disease is constantly evolving. Survival outcomes for patients with colorectal cancer metastatic to the liver are poor, although a subset of patients with limited or “oligometastatic” disease may exist in a therapeutic window amenable to aggressive local intervention. The purpose of this review is to describe and compare the range of non-surgical local treatment options available for the treatment of oligometastatic colorectal disease involving the liver.",

keywords = "Chemoembolization, Intra-arterial chemotherapy, Limited metastatic disease, Liver brachytherapy, Liver metastases, Liver-directed therapy, Metastatic colorectal cancer, Oligometastases, Radioembolization, Radiofrequency ablation, SBRT, SIRT, Selective internal radiation therapy, Stereotactic body radiation therapy",

author = "Folkert, {Michael R.} and Jeffrey Meyer",

note = "Funding Information: Jeffrey Meyer has received clinical research trial support from Peregrine Pharmaceuticals, Inc., compensation from UpToDate, Inc., and Osler Review for service as a consultant, and research support through grants from Cancer Prevention and Research Institute of Texas and the American Cancer Society. Publisher Copyright: {\textcopyright} 2015, Springer Science+Business Media New York.",

year = "2015",

month = oct,

day = "28",

doi = "10.1007/s11888-015-0279-0",

language = "English (US)",

volume = "11",

pages = "241--249",

journal = "Current Colorectal Cancer Reports",

issn = "1556-3790",

publisher = "Springer",

number = "5",

}

TY - JOUR

T1 - Local Therapy Options for Oligometastatic Disease in the Liver

AU - Folkert, Michael R.

AU - Meyer, Jeffrey

N1 - Funding Information: Jeffrey Meyer has received clinical research trial support from Peregrine Pharmaceuticals, Inc., compensation from UpToDate, Inc., and Osler Review for service as a consultant, and research support through grants from Cancer Prevention and Research Institute of Texas and the American Cancer Society. Publisher Copyright: © 2015, Springer Science+Business Media New York.

PY - 2015/10/28

Y1 - 2015/10/28

N2 - Our understanding of metastatic disease is constantly evolving. Survival outcomes for patients with colorectal cancer metastatic to the liver are poor, although a subset of patients with limited or “oligometastatic” disease may exist in a therapeutic window amenable to aggressive local intervention. The purpose of this review is to describe and compare the range of non-surgical local treatment options available for the treatment of oligometastatic colorectal disease involving the liver.

AB - Our understanding of metastatic disease is constantly evolving. Survival outcomes for patients with colorectal cancer metastatic to the liver are poor, although a subset of patients with limited or “oligometastatic” disease may exist in a therapeutic window amenable to aggressive local intervention. The purpose of this review is to describe and compare the range of non-surgical local treatment options available for the treatment of oligometastatic colorectal disease involving the liver.

KW - Chemoembolization

KW - Intra-arterial chemotherapy

KW - Limited metastatic disease

KW - Liver brachytherapy

KW - Liver metastases

KW - Liver-directed therapy

KW - Metastatic colorectal cancer

KW - Oligometastases

KW - Radioembolization

KW - Radiofrequency ablation

KW - SBRT

KW - SIRT

KW - Selective internal radiation therapy

KW - Stereotactic body radiation therapy

UR - http://www.scopus.com/inward/record.url?scp=84940451766&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84940451766&partnerID=8YFLogxK

U2 - 10.1007/s11888-015-0279-0

DO - 10.1007/s11888-015-0279-0

M3 - Review article

AN - SCOPUS:84940451766

SN - 1556-3790

VL - 11

SP - 241

EP - 249

JO - Current Colorectal Cancer Reports

JF - Current Colorectal Cancer Reports

IS - 5

ER -

Local Therapy Options for Oligometastatic Disease in the Liver

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this